Roots Analysis Identifies Top 7 DNA Synthesis Companies

Roots Analysis, a company focused on AI and synthetic biology, released its assessment of 7 leading DNA synthesis companies in April 2024. The firm analyzed over 65 players in the DNA synthesis sector to identify those offering efficient technologies and services.

The significance of DNA synthesis spans from genetic research and the diagnosis of genetic diseases to applications in synthetic biology for industry and agriculture. Recent advancements in molecular biology and the adoption of new synthesis methods, such as enzymatic platforms, have accelerated the field. Notably, the COVID-19 pandemic spurred the development of DNA- and RNA-based vaccines and therapies.

According to Roots Analysis, many companies have developed proprietary enzymatic DNA synthesis platforms that offer advantages over traditional methods, including longer DNA fragments and improved scalability. The industry's growth is also influenced by drug developers and researchers outsourcing DNA synthesis services to specialized third-party providers.

The seven companies listed were selected based on company size. However, Roots Analysis notes that the selection of top players can vary significantly based on the defined criteria. The companies identified include Ajinomoto Bio-Pharma Services, ATUM, DNA Script, Eurofins Genomics, Gene Universal, GenScript, and Synbio Technologies, each offering distinct solutions in the DNA synthesis domain.